Sangamo Therapeutics (SGMOQ) EBITDA Margin Growth (1y) (2011 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) EBITDA Margin Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn | 798.00 |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | 2.46 Mn |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | 13,751.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 2,348.00 |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | -6,012.00 |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | -2.44 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 375,193.00 |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn | -1,560.00 |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | 377.00 |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | 13,134.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 13,134.00 |
| Sep 30, 2025 | -614,079.00 |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 263,928.00 |
| Sep 30, 2024 | 115,376.00 |
| Jun 30, 2024 | -860,892.00 |
| Mar 31, 2024 | -1.07 Mn |
| Dec 31, 2023 | -283,571.00 |
| Sep 30, 2023 | -92,478.00 |
| Jun 30, 2023 | -165,226.00 |
| Mar 31, 2023 | 17,174.00 |
| Dec 31, 2022 | -6,085.00 |
| Sep 30, 2022 | -3,788.00 |
| Jun 30, 2022 | 1,905.00 |
| Mar 31, 2022 | 1,586.00 |
| Dec 31, 2021 | 2,577.00 |
| Sep 30, 2021 | -16,317.00 |
| Jun 30, 2021 | 110.00 |
| Mar 31, 2021 | 16,430.00 |